CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.450 GBX | -1.69% |
|
-4.92% | +31.82% |
| 07-06 | CelLBxHealth chief executive Collins to step down | AN |
| 07-06 | Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer | CI |
| Market Cap | 16.76M 22.4M 19.65M 18.14M 31.77M 2.14B 32.41M 218M 84.73M 1.05B 84.12M 82.28M 3.64B | P/E 2025 * |
-0.26x | P/E 2026 * | -0.63x |
|---|---|---|---|---|---|
| Enterprise Value | 9.46M 12.64M 11.09M 10.24M 17.93M 1.21B 18.29M 123M 47.83M 593M 47.48M 46.44M 2.06B | EV / Sales 2025 * |
0.91x | EV / Sales 2026 * | 0.7x |
| Free-Float |
94.31% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: CelLBxHealth plc
| 25-10-16 | Angle names Peter Collins as interim CEO | AN |
| 25-05-28 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 25-01-23 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 23-09-14 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 22-01-24 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | -1.69% | ||
| 1 week | -4.92% | ||
| Current month | -4.92% | ||
| 1 month | -15.94% | ||
| 3 months | +61.11% | ||
| 6 months | +38.10% | ||
| Current year | +31.82% |
| 1 week | 1.41 |  | 1.67 |
| 1 month | 1.3 | | 2 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 1998-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2024-12-31 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 2023-05-21 |
Klaas de Boer
BRD | Director/Board Member | 61 | 2026-01-11 |
| Director/Board Member | 61 | 2026-01-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-18 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 12-18 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 12-18 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.69% | -4.92% | -77.69% | -87.66% | 22.42M | |
| -5.12% | -3.97% | -0.86% | -28.31% | 16.54B | |
| -1.77% | +7.28% | +29.90% | +88.65% | 1.65B | |
| -3.82% | -10.73% | -47.34% | -80.92% | 1.16B | |
| -0.39% | -1.74% | -29.05% | +33.19% | 1.1B | |
| +0.29% | +0.58% | -28.86% | -54.68% | 613M | |
| -2.23% | -7.65% | -41.81% | -58.26% | 550M | |
| +2.21% | +2.20% | +29.48% | -52.91% | 449M | |
| -0.96% | +1.47% | -54.85% | -59.64% | 382M | |
| -3.37% | -3.65% | -27.79% | -27.71% | 337M | |
| Average | -1.50% | -0.72% | -24.89% | -32.83% | 2.28B | |
| Weighted average by Cap. | -3.88% | +0.38% | -4.87% | -22.05% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.35M 13.84M 12.14M 11.21M 19.63M 1.32B 20.02M 135M 52.34M 648M 51.96M 50.83M 2.25B | 21.65M 28.93M 25.38M 23.43M 41.04M 2.77B 41.86M 282M 109M 1.36B 109M 106M 4.71B |
| Net income | -16.35M -21.85M -19.16M -17.69M -30.99M -2.09B -31.61M -213M -82.64M -1.02B -82.05M -80.25M -3.55B | -8.55M -11.43M -10.02M -9.25M -16.21M -1.09B -16.53M -111M -43.22M -535M -42.91M -41.97M -1.86B |
| Net Debt | -7.3M -9.76M -8.56M -7.9M -13.84M -934M -14.11M -94.97M -36.9M -457M -36.64M -35.83M -1.59B | -1.6M -2.14M -1.88M -1.73M -3.03M -205M -3.09M -20.81M -8.09M -100M -8.03M -7.85M -348M |
Employees
119
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | GBX 1.450 | -1.69% | 2,251,058 |
| 26-07-07 | GBX 1.475 | -7.81% | 4,128,376 |
| 26-07-06 | GBX 1.600 | +6.67% | 2,912,628 |
| 26-07-03 | GBX 1.500 | 0.00% | 716,727 |
| 26-07-02 | GBX 1.500 | -1.64% | 973,749 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0148GBP
Average target price
0.0400GBP
Spread / Average Target
+171.19%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
